142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

Prescription Opioid Pain Reliever and Other Drug Overdoses Among Women United States, 19992010

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 12:50 PM - 1:10 PM

Karin A. Mack, PhD , Division of Analysis, Research and Practice Integraiton, CDC's Injury Center, Atlanta, GA
Background: In 2013, CDC called attention to the dramatic rise in prescription opioid pain reliever (OPR) overdose deaths among women. These analyses extend that work by examining drug overdose deaths among women in more detail.

Methods:  Fatal overdoses among women were analyzed using the National Vital Statistics System multiple cause of death files (1999–2010). Drug poisoning (overdose) deaths were classified using the International Classification of Diseases 10th Revision (ICD-10) underlying cause of death external cause of injury codes (X40-X44, X60-X64, X85, or Y10-Y14). Analyses include deaths of any intent for US residents. Type of drug was based on ICD-10 codes for OPR (T40.2-T40.4), benzodiazepines (T42.4), antidepressants (T43.0-T43.2), heroin (T40.1), and cocaine (T40.5).

Results: There was a 415% increase in number of OPR-related deaths among women between 1999-2010. In each year, over half of OPR-related deaths did not involve other drugs such as benzodiazepines, antidepressants, cocaine, or heroin.  The number of OPR deaths that also included a benzodiazepine increased over 900% between 1999-2010; the number of OPR deaths that also included an antidepressant increased 390%.  Heroin-related overdose deaths not involving antidepressants, benzodiazepines, cocaine, or OPR remained relatively low (341 deaths in 2010) but increased 143%; cocaine-related deaths not involving benzodiazepines, antidepressants, heroin, or OPR increased 3% (597 deaths in 2010).

Conclusions: Results detail changing nature of overdoses among women. Understanding these changes, such as rising involvement of psychotherapeutic drugs, provides insight for prevention. Providers who treat women for pain should follow prescribing guidelines and screen for use of psychotherapeutic drugs.

Learning Areas:

Public health or related research
Social and behavioral sciences

Learning Objectives:
Describe changing nature of drug overdoses among women

Keyword(s): Drug Abuse Prevention and Safety, Women's Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Associate Director for Science for the Division of Analysis, Research, and Practice Integration @ CDC's Injury Center. I have over 10 years experience as injury prevention researcher.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.